Bryan M. Webb

444 total citations
10 papers, 323 citations indexed

About

Bryan M. Webb is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Bryan M. Webb has authored 10 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Hematology. Recurrent topics in Bryan M. Webb's work include Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Bryan M. Webb is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Ubiquitin and proteasome pathways (3 papers) and Multiple Myeloma Research and Treatments (2 papers). Bryan M. Webb collaborates with scholars based in United States and Netherlands. Bryan M. Webb's co-authors include Stanton L. Gerson, Amar Desai, Ruth A. Keri, Darcie D. Seachrist, Igor R. Efimov, Christine P. Fleming, Andrew M. Rollins, Crystal M. Ripplinger, Raffaella Spina and Eli E. Bar and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Radiotherapy and Oncology.

In The Last Decade

Bryan M. Webb

10 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bryan M. Webb United States 8 199 107 68 53 34 10 323
Marie‐Therese Haider Germany 11 150 0.8× 232 2.2× 86 1.3× 23 0.4× 57 1.7× 16 332
Timo Korb Germany 5 113 0.6× 219 2.0× 56 0.8× 48 0.9× 34 1.0× 5 359
Christina Barckhausen Germany 7 223 1.1× 86 0.8× 66 1.0× 20 0.4× 26 0.8× 9 320
Victoria M.-Y. Wang United Kingdom 6 179 0.9× 141 1.3× 99 1.5× 47 0.9× 36 1.1× 8 344
Marta Popęda Poland 13 156 0.8× 142 1.3× 87 1.3× 19 0.4× 79 2.3× 32 350
Fumitake Kai Japan 10 220 1.1× 231 2.2× 100 1.5× 34 0.6× 117 3.4× 19 436
Johanna Mangana Switzerland 10 126 0.6× 229 2.1× 24 0.4× 53 1.0× 51 1.5× 13 344
Yongzhang Luo China 9 221 1.1× 180 1.7× 69 1.0× 14 0.3× 39 1.1× 12 381
Sander B. Frank United States 10 169 0.8× 78 0.7× 70 1.0× 26 0.5× 98 2.9× 12 292
Michael M. Allevato United States 7 178 0.9× 145 1.4× 61 0.9× 19 0.4× 56 1.6× 15 336

Countries citing papers authored by Bryan M. Webb

Since Specialization
Citations

This map shows the geographic impact of Bryan M. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan M. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan M. Webb more than expected).

Fields of papers citing papers by Bryan M. Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bryan M. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan M. Webb. The network helps show where Bryan M. Webb may publish in the future.

Co-authorship network of co-authors of Bryan M. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Bryan M. Webb. A scholar is included among the top collaborators of Bryan M. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bryan M. Webb. Bryan M. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Anstine, Lindsey J., Salendra Singh, Fadi W. Abdul‐Karim, et al.. (2023). TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. Cancer Research. 83(7). 997–1015. 3 indexed citations
2.
Webb, Bryan M., et al.. (2023). Disruption of CDK7 signaling leads to catastrophic chromosomal instability coupled with a loss of condensin-mediated chromatin compaction. Journal of Biological Chemistry. 299(7). 104834–104834. 6 indexed citations
3.
Webb, Bryan M., et al.. (2021). TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters. Journal of Biological Chemistry. 297(4). 101162–101162. 9 indexed citations
4.
5.
Seachrist, Darcie D., Bryan M. Webb, Peng Yu, et al.. (2020). The transcriptional repressor BCL11A promotes breast cancer metastasis. Journal of Biological Chemistry. 295(33). 11707–11719. 20 indexed citations
7.
Webb, Bryan M., Darcie D. Seachrist, Salendra Singh, et al.. (2017). Mitotic Vulnerability in Triple-Negative Breast Cancer Associated with LIN9 Is Targetable with BET Inhibitors. Cancer Research. 77(19). 5395–5408. 24 indexed citations
8.
Webb, Bryan M., Erika K. Ramos, Darcie D. Seachrist, et al.. (2016). Bromodomain and Extraterminal Protein Inhibition Blocks Growth of Triple-negative Breast Cancers through the Suppression of Aurora Kinases. Journal of Biological Chemistry. 291(45). 23756–23768. 47 indexed citations
9.
Desai, Amar, Bryan M. Webb, & Stanton L. Gerson. (2014). CD133+ cells contribute to radioresistance via altered regulation of DNA repair genes in human lung cancer cells. Radiotherapy and Oncology. 110(3). 538–545. 91 indexed citations
10.
Fleming, Christine P., Crystal M. Ripplinger, Bryan M. Webb, Igor R. Efimov, & Andrew M. Rollins. (2008). Quantification of cardiac fiber orientation using optical coherence tomography. Journal of Biomedical Optics. 13(3). 30505–30505. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026